Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCCNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FK.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.21.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FP.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.92NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.35.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GE.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HE.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.4.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.99NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FE.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.20.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.110NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.86.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GN.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.8.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HB.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.10.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.89NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GR.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.568NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.13 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.372NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.634NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.37.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.630NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.360NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.4.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.9.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDBNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used